Académique Documents
Professionnel Documents
Culture Documents
net/journal/0271-
1206_Topics_in_hospital_pharmacy_management_Aspen_Systems_Corporation
Additional details
Cited half-life 0.00
Eigenfactor 0.00
ISSN 0271-1206
OCLC 6550764
Learn more
D R Saine
M L Ryan B W Chaffee
K E Koch
B G Peters
K W Kolb
R Shane B Vinson
B S Grabowski
J P Juergens L R Basara
A L Wilson
S O Price M A Newnham
[Show abstract] [Hide abstract]ABSTRACT: The purpose of this study was to classify
pharmacist-physician encounters in a family medicine center into three progressive
levels of service in order to determine the physician's perception of the relative value of
each level. The three levels of service were drug information, pharmacy consultation
individualized to the patient, and pharmaceutical care-consultation with follow-up to
monitor patient outcome. Physicians received a questionnaire with each encounter and
were asked to rank questions regarding the quality of the information provided, the
impact they perceived that the information had on patient care, and to assign a
monetary value for each encounter. A total of 106 of 141 (75 percent) questionnaires
suitable for analysis were stratified into drug information (25.5 percent), pharmacy
consultation (49 percent), and pharmaceutical care (25.5 percent). Physicians'
perceptions toward the quality, impact, and value of pharmacy services were favorable
overall, but they perceived a significantly higher quality, impact, and value to
pharmaceutical care encounters than for drug information and pharmacy consultation (p
< 0.05).
Article: Influencing prescribing practices and associated outcomes utilizing the drug use
evaluation process
S G Yackzan
B G Peters
[Show abstract] [Hide abstract]ABSTRACT: Understanding the toxicities associated
with cancer chemotherapeutic agents is essential to pharmacists involved in the clinical
management of oncology patients. Anticipation of various treatment-related toxicities
may provide the opportunity for pharmacists to develop intervention strategies that
could minimize or eliminate an expected side effect of chemotherapy such as
myelosuppression, nausea, or emesis. Effective management of chemotherapy
toxicities may lead to decreased lengths of stay in the hospital or administration of
chemotherapy in the outpatient setting. This article addresses the onset of
chemotherapy toxicities, the major organ system toxicities, and the management of
many of these chemotherapy-induced toxicities. Chemotherapy dose modifications are
discussed as well as maximum lifetime doses and the use of prophylactic medications
to prevent various side effects.
M C Lunik
[Show abstract] [Hide abstract]ABSTRACT: Early recognition and prompt control are
the two major factors in dealing with oncologic emergencies. The most common
emergencies are tumor lysis syndrome, hypercalcemia, spinal cord compression, and
superior vena cava syndrome. Emergencies in cancer can occur at any stage of the
disease process or its treatment. It is very important that caregivers are able to
recognize and manage these emergencies; serious complications can arise if they are
not treated promptly.
B R Harrison
12345
Data provided are for informational purposes only. Although carefully collected,
accuracy cannot be guaranteed. Publisher conditions are provided by RoMEO. Differing
provisions from the publisher's actual policy or licence agreement may be applicable.
Bottom of Form
or
Abstract
Research opportunities in hospital pharmacy, especially in administrative and managerial areas, are
discussed. Six areas of hospital pharmacy practice that have potential for research are discussed:
personnel, inventory, services, evaluation, management, and research/education. Specific topics
mentioned are employee satisfaction, technicians and their impact on hospital pharmacy, purchasing, use
of electronic data processing in inventory control, extent of decentralization of pharmaceutical services,
pharmacy and therapeutics committees, reimbursement for consultations and pharmacokinetics services,
quality assurance, evaluation of pharmacy management, and the cost-benefit ratio of research and
education activities.